+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gene Editing"

Whole Genome Synthesis - Global Strategic Business Report - Product Thumbnail Image

Whole Genome Synthesis - Global Strategic Business Report

  • Report
  • August 2025
  • 378 Pages
  • Global
From
From
Targeted Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Targeted Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 382 Pages
  • Global
From
Optogenetics - Global Strategic Business Report - Product Thumbnail Image

Optogenetics - Global Strategic Business Report

  • Report
  • August 2025
  • 107 Pages
  • Global
From
RNA-based Therapeutics - Global Strategic Business Report - Product Thumbnail Image

RNA-based Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 274 Pages
  • Global
From
Regenerative Therapies - Global Strategic Business Report - Product Thumbnail Image

Regenerative Therapies - Global Strategic Business Report

  • Report
  • August 2025
  • 287 Pages
  • Global
From
From
m-RNA Synthesis Services - Global Strategic Business Report - Product Thumbnail Image

m-RNA Synthesis Services - Global Strategic Business Report

  • Report
  • August 2025
  • 227 Pages
  • Global
From
Hyper Personalized Medicines - Global Strategic Business Report - Product Thumbnail Image

Hyper Personalized Medicines - Global Strategic Business Report

  • Report
  • August 2025
  • 390 Pages
  • Global
From
Cell Transfection - Global Strategic Business Report - Product Thumbnail Image

Cell Transfection - Global Strategic Business Report

  • Report
  • August 2025
  • 294 Pages
  • Global
From
Glycomic Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glycomic Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 401 Pages
  • Global
From
From
CRISPR Genomic Cure - Global Strategic Business Report - Product Thumbnail Image

CRISPR Genomic Cure - Global Strategic Business Report

  • Report
  • August 2025
  • 282 Pages
  • Global
From
From
Pharmacogenomics Technology - Global Strategic Business Report - Product Thumbnail Image

Pharmacogenomics Technology - Global Strategic Business Report

  • Report
  • August 2025
  • 291 Pages
  • Global
From
DNA Repair Drugs - Global Strategic Business Report - Product Thumbnail Image

DNA Repair Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 217 Pages
  • Global
From
Allogeneic Cell Therapy - Global Strategic Business Report - Product Thumbnail Image

Allogeneic Cell Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 275 Pages
  • Global
From
From
gRNA - Global Strategic Business Report - Product Thumbnail Image

gRNA - Global Strategic Business Report

  • Report
  • August 2025
  • 475 Pages
  • Global
From
From
Loading Indicator

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease. Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more